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Abstract
Background: To study the influence of a nationwide albuminuria self-test program on the number of GP contacts
for urinary complaints and/or kidney diseases and the number of newly diagnosed patients with kidney diseases
by the GP.
Methods: Data were used from the Netherlands Information Network of General Practice (LINH), including a
representative sample of general practices with a dynamic population of approximately 300.000 listed patients.
Morbidity data were retrieved from electronic medical records, kept in a representative sample of general practices.
The incidence of kidney diseases and urinary complaints before and after the albuminuria self-test program was
compared with logistic regression analyses.
Results: Data were used from 139 general practices, including 444,220 registered patients. The number of GP
consultations for kidney diseases and urinary complaints was increased in the year after the albuminuria self-test
program and particularly shortly after the start of the program. Compared with the period before the self-test
program, more patients have been diagnosed by the GP with symptoms/complaints of kidney disease and urinary
diseases (OR = 1.7 (CI 1.4 - 2.0) and OR = 2.1 (CI 1.9 - 2.3), respectively). The odds on an abnormal urine-test in the
period after the self-test program was three times higher than the year before (OR = 3.0 (CI 2.4 - 3.6)). The effect of
the self-test program on newly diagnosed patients with an abnormal urine test was modified by both the
presence of the risk factors hypertension and diabetes mellitus. For this diagnosis the highest OR was found in
patients without both conditions (OR = 4.2 (CI 3.3 - 5.4)).
Conclusions: A nationwide albuminuria self-test program resulted in an increasing number of newly diagnosed
kidney complaints and diseases the year after the program. The highest risks were found in patients without risk
factors for kidney diseases.
Background
Because of the increasing prevalence rate of lifestyle-
related diseases such as cardiovascular diseases and dia-
betes mellitus [1-3], but also chronic kidney diseases,
population-based prevention strategies are needed to
prevent future problems for patients and to reduce costs
for health care. Therefore, screening for risk factors of
these chronic diseases in the general population
becomes more popular. In 2006, the Dutch Kidney
Foundation started a program to detect persons at risk
for chronic renal failure (CRF) in the Netherlands by
offering a free self-test for albuminuria [4]. Patients with
CRF have structural abnormalities of the kidney result-
ing in decreased kidney function, necessitating dialysis
or kidney transplantation [5].
With advertisements on the radio, television, newspa-
pers and the Internet, Dutch adults over the age of 18
were invited to order the free albuminuria self-test via
the Internet or by telephone in the period September
until November 2006. The presence of an increased
amount of albumin in the urine is an indicator for wor-
sening kidney function and increases the risk of devel-
oping CRF. In case of a positive test result, participants
were advised to visit their General Practitioner (GP) for
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additional examination and treatment [4]. In the Neth-
erlands, the GP has a gatekeeper role for access to spe-
cialized care. All Dutch citizens are listed with a general
practice and the GP is usually the first professional to
be consulted with health problems.
In a previous study the usefulness of the albuminuria
self-test program was investigated in a population of
participants who ordered the self-test [4,6]. From that
study it was concluded that more than half of the adult
Dutch population was aware of the self-test program
and over one million persons (about 9% of the Dutch
adult population) ordered the self-test via the Internet
in the first 30 days of the program. Also GP visits fol-
lowing a positive test result have contributed to newly
detected patients with kidney diseases, hypertension
and/or diabetes mellitus. Besides these positive findings,
there were also some negative side-effects, which are
common in screening programs in the general popula-
tion. A large number of (probably) false positive test
results were found. This causes worries among the test
users, unnecessary use of health care and therefore
unnecessary costs. Also, due to the low a-priori risk on
CRF in the general population, it would have been bet-
ter to test in populations at high risk. Finally, only a
small proportion of the persons with a positive test
result (25%) visited a GP for additional examination
and/or treatment within eight weeks after testing [4].
Given the high awareness of the self-test program, it is
likely that the program not only resulted directly in
newly detected diseases, but also indirectly led to an
increased number of newly detected kidney diseases,
since 1) instead of self-testing, patients could have
decided to visit their GP for testing the renal function,
and 2) GPs could have become more focused on the
detection of kidney diseases as a result of the program. In
our previous study questionnaires of participants were
used and therefore it was not possible to determine the
consequences of the self-test program for the GP.
Therefore, in this study we have investigated the influ-
ence of the screening program on the number of GP
contacts for urinary complaints and/or kidney diseases
and the number of newly diagnosed patients with kidney
diseases by the GP. Accordingly, the following research
questions were formulated: 1) Are there differences in
the total number of GP contacts for urinary complaints
and/or kidney diseases before and after the albuminuria
self-test program?, 2) Are there differences in the num-
ber of newly diagnosed patients with kidney diseases by
the GP before and after the albuminuria self-test pro-
gram?, and 3) Are there differences in the number of
newly diagnosed patients in persons with hypertension
and/or diabetes mellitus and patients without these risk
factors before and after the albuminuria self-test
program?
Methods
Netherlands Information Network of General Practice
Data were used from the Netherlands Information Net-
work of General Practice (LINH). Data were retrieved
from electronic medical records, kept in a representative
sample of general practices with approximately 300.000
listed patients in 2008 [7]. Data include information on
consultations, morbidity, prescriptions and referrals. The
characteristics of the study population (practices as well
as patients) were comparable with the Dutch population
in terms of age and gender [8]. Diagnoses were recorded
using the ICPC-1 coding system (International Classifi-
cation of Primary Care) [9]. When issuing a prescrip-
tion, a diagnostic code was recorded, and the selected
drug was automatically linked to the Anatomical Thera-
peutic Chemical (ATC) Classification System http://
www.whocc.no/.
The study was carried out according to Dutch legisla-
tion on privacy. The privacy regulation of the study was
registered at the Dutch Data Protection Authority.
According to Dutch legislation, nor obtaining informed
consent nor approval by a medical ethics committee was
obligatory for observational studies.
Design and study population
In this study the number of contacts with the GP for kid-
ney diseases and/or urinary complaints and the number of
newly diagnosed patients with kidney diseases were com-
pared between the year before and after the albuminuria
self-test program. The period before the program was
from 1 September 2005 to 31 August 2006 (Period 1) and
the period after the program was from 1 November 2006
to 31 October 2007 (Period 2). The two months in
between were not included in the study, because there was
a delay between the start of the program at 1 September
2006 and the first GP visits by participants with a positive
test result (caused by delivering of the self-test by post,
testing for albuminuria and eventually visiting the GP).
Data are used from a dynamic population and include
all consultations from patients who were registered at a
LINH practice at any time during the study period (1
September 2005 to 31 October 2007). We used a
dynamic population, because the group of registered
patients at a GP practices is not fixed (patients change
their GP, relocate or die). In case a patient was not
registered the whole study period -when a general prac-
tice did not deliver data during the whole study period
or when patients were registered temporarily-, a ‘time at
risk’ was calculated. Patients who were under the age of
18 at the start of the self-test program (1 September
2006) were excluded, because the self-test was meant to
be used by adults.
Per selected patient we determined if they were diag-
nosed in a period of three years before the first study
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year with one of the following kidney diseases/urinary
complaints: U07 (Urine symptom/complaint, other),
U14 (Kidney symptom/complaint), U27 (Fear of urinary
disease), U29 (Urinary symptom/complaint, other), U98
(Abnormal urine test) and U99 (Urinary disease, other
(renal failure)). Furthermore the presence of risk factors
for chronic kidney disease, i.e. diabetes mellitus (ICPC
code T90), hypertension (ICPC code K86 and/or K87),
at the start of the study period was determined.
Statistical analyses
Three different statistical analyses were performed. First,
a descriptive analysis was performed to determine the
course of the number of consultations per week with
the GP for kidney diseases and urinary complaints (one
of the following ICPC codes: U07, U14, U27, U29, U98
or U99) over the whole study period. The number of
consultations was divided by the total number of con-
tacts in that week to correct for seasonal fluctuations in
the number of GP contacts. To adjust for outliers, a 4-
week moving average was calculated and plotted.
Second, per kidney disease/urinary complaint the abso-
lute number of newly diagnosed patients was determined
for the period before and after the self-test program. In
addition, the absolute number of cases and the total ‘time
at risk’ of all patients in the specified periods were used
to calculate person-time incidence rates (IR) per 10,000
person years. The IR of both periods were used to calcu-
late incidence rate ratio’s (IRR) with 95% confidence
intervals. IRs and IRRs were calculated for the total study
population and stratified by age (age groups 18-45 years,
46-65 years and 66 years and older), presence of hyper-
tension and presence of diabetes mellitus, which are all
risk factors for chronics kidney diseases.
Third, per kidney disease/urinary complaint the num-
ber of newly diagnosed patients by the GP in the period
before the self-test program were compared with the
number of newly diagnosed patients in the period after
the self-test program with logistic regression analyses.
The models were adjusted for age and gender and the
presence of hypertension and diabetes mellitus. Odds
ratios (ORs) are reported with 95% confidence intervals.
In addition, it was tested if the presence of these risk
factors for kidney diseases modified the effect of the
self-test program on the number of newly detected kid-
ney diseases by adding interaction terms to the model.
If the interaction was statistically significant (p-value <
0.05), ORs were presented for subgroups. All statistical
analyses were performed with Stata 11.
Results
Characteristics of the study population
Data from 81 out of the 85 (95.3%) participating LINH
practices in 2005 could be used for statistical analyses.
Four practices had to be excluded because of missing
data. In 2006 and 2007, 58 new general practices were
included in LINH. In total, data were used from 139
general practices, including 444,220 registered patients.
Of these patients, 227,393 were female (51%) and the
largest age group was 36-45 years old (see table 1). At
the start of the study period, 6,005 patients were already
diagnosed with a kidney disease or an urinary complaint,
34,022 patients were diagnosed with hypertension and
12,552 patients with diabetes mellitus.
Number of GP contacts for kidney diseases
The number of GP consultations for kidney diseases and
urinary complaints per 10,000 consultations is plotted in
Figure 1. The number of GP consultations fluctuated
between 20 and 25 per 10,000 consultations in period 1.
This rate increased by approximately 5 per 10,000 con-
sultations to 25 to 30 per 10,000 consultations in period
2. Moreover, the number of consultations increased in
the first four weeks of period 2 to as high as an addi-
tional 10 per 10,000 consultations.
Newly diagnosed kidney diseases in the period before
and after the self-test program
The IRs of kidney diseases/urinary complaints in the
period before and after the albuminuria self-test pro-
gram are shown in table 2. These IRs were used to cal-
culate IRRs for the total population and subgroups. In
the total study population, statistical significant IRRs
were found for the diagnoses U14 (Kidney symptom/
complaint), U98 (Abnormal urine test) and U99 (Urin-
ary disease, other (renal failure)). For the diagnosis U14
the IR increased from 4.4 to 6.9 per 10,000 person
years, resulting in a 1.6 times higher IR in the period
Table 1 Population characteristics at baseline (1
September 2005)






18-25 years 66,677 15.0
26-35 years 83,919 18.9
36-45 years 91,255 20.5
46-55 years 76,679 17.3
56-65 years 58,968 13.3
66-75 years 37,783 8.5
76-85 years 22,997 5.2
85+ years 5,942 1.3
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after the self-test program compared with the year
before the program. This effect was found in all age
groups and in subjects without hypertension and dia-
betes mellitus. The IR of the diagnoses U98 and U99
increased from 3.6 to 10.0 per 10,000 person years and
from 13.8 to 25.8 per 10,000 person years, respectively.
This resulted in IRRs of 2.8 (CI 2.3 - 3.4) and 1.9 (CI
1.7 - 2.1) for the diagnoses U98 and U99, respectively.
The increase of the number of abnormal urine tests
(U98) was the highest in the age category 18-45 years
old (IRR 4.2 (CI 2.8 - 6.3)). The IR of urinary diseases
(U99) was increased in all subgroups the year after the
program and the IRR varied between 1.7 and 2.1.
Logistic regression analyses
The results of the logistic regression analyses are shown
in table 3. Odds ratios (ORs), adjusted for age, gender
and the presence of hypertension and diabetes mellitus,
were calculated for six kidney diseases/urinary com-
plaints. There were no significant ORs found for the
diagnoses U29 (Urinary symptom/complaint, other) and
U27 (Fear of urinary disease). However, for diagnosis
U27 we found statistical significant interaction with the
presence of hypertension and diabetes mellitus (p = 0.01
and p = 0.02, respectively). Patients with hypertension
and diabetes mellitus had a lower odds of being diag-
nosed with fear of urinary disease (U27) the period after
the self-test program (OR = 0.6 and OR = 0.5,
respectively).
The year after the self-test program, there was a
higher odds of being diagnosed with the following diag-
noses: U07 (Urine symptom/complaint, other), U14
(Kidney symptom/complaint), U98 (Abnormal urine
test) and U99 (Urinary disease, other (renal failure))
with the highest OR for an abnormal urine test (OR =
3.0 (CI 2.4 - 3.6)). The effect of the self-test program on
newly diagnosed patients with an abnormal urine test
(ICPC code U98) was modified by both the presence of
hypertension and diabetes mellitus. For this diagnosis,
the highest OR was found for patients without both
conditions (OR = 4.2 (CI 3.3 - 5.4)). Furthermore, for
the diagnosis ‘Urinary disease’ (ICPC code U99), the
odds of being newly diagnosed was higher in patients
without diabetes mellitus (OR = 2.3 (CI 2.0-2.6) versus
OR 1.4 (CI 1.1-1.9) in patients with diabetes).
Discussion
The number of GP consultations for kidney diseases and
urinary complaints increased in the year after the albu-
minuria self-test program and particularly shortly after
the start of the program. Compared with the year before
the self-test program, 1.7 times more patients have been
diagnosed by the GP with symptoms/complaints of kid-
ney disease and 2.1 times more patients with urinary
diseases. The odds of an abnormal urine-test in the per-
iod after the self-test program was 3.0 times higher than
the year before. The effect of the self-test program on
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Figure 1 Number of GP consultations per week for kidney diseases/urinary complaints per 10,000 consultations.
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Table 2 Incidence rates of kidney diseases/urinary complaints in general practice before (period 1) and after (period
2) the albuminuria self-test program per 10,000 person years in the total population and in subgroups










ICPC U07: Urine symptoms/
complaint
548 14.9 625 15.6 1.0 (0.9 - 1.2)
18-45 years old 220 11.1 257 11.8 1.1 (0.9 - 1.3)
46-65 years old 146 12.9 186 15.2 1.2 (0.9 - 1.5)
> 65 years old 182 32.9 182 30.6 0.9 (0.8 - 1.1)
Hypertension, yes 96 33.5 86 33.2 1.0 (0.7 - 1.3)
Hypertension, no 452 13.3 539 14.4 1.1 (1.0 - 1.2)
Diabetes mellitus, yes 61 52.4 49 46.2 0.9 (0.6 - 1.3)
Diabetes mellitus, no 487 13.7 576 14.8 1.1 (1.0 - 1.2)
ICPC U14: Kidney symptoms/
complaint
161 4.4 277 6.9 1.6 (1.3 - 1.9)*
18-45 years old 63 3.2 117 5.4 1.7 (1.2 - 2.3)*
46-65 years old 61 5.4 92 7.5 1.4 (1.0 - 2.0)*
> 65 years old 37 6.7 68 11.3 1.7 (1.1 - 2.6)*
Hypertension, yes 29 10.1 30 11.5 1.1 (0.7 - 2.0)
Hypertension, no 132 3.9 247 6.6 1.7 (1.4 - 2.1)*
Diabetes mellitus, yes 14 11.9 12 11.1 0.9 (0.4 - 2.2)
Diabetes mellitus, no 147 4.1 265 6.8 1.6 (1.3 - 2.0)*
ICPC U27: Fears of urinary
disease
424 11.6 450 11.3 1.0 (0.9 - 1.1)
18-45 years old 207 10.5 204 9.4 0.9 (0.7 - 1.1)
46-65 years old 123 10.9 137 11.2 1.0 (0.8 - 1.3)
> 65 years old 94 17.0 109 18.3 1.1 (0.8 - 1.4)
Hypertension, yes 87 30.7 51 19.9 0.6 (0.4 - 0.9)*
Hypertension, no 337 10.0 399 10.7 1.1 (0.9 - 1.2)
Diabetes mellitus, yes 37 32.0 17 16.1 0.5 (0.3 - 0.9)*
Diabetes mellitus, no 387 10.9 433 11.2 1.0 (0.9 - 1.2)
ICPC U29: Urinary symptoms/
complaint
94 2.6 112 2.8 1.1 (0.8 - 1.5)
18-45 years old 32 1.6 47 2.2 1.3 (0.8 - 2.2)
46-65 years old 27 2.4 28 2.3 1.0 (0.5 - 1.7)
> 65 years old 35 6.3 37 6.2 1.0 (0.6 - 1.6)
Hypertension, yes 14 4.8 16 6.1 1.3 (0.6 - 2.8)
Hypertension, no 80 2.4 96 2.6 1.1 (0.8 - 1.5)
Diabetes mellitus, yes 6 5.1 6 5.6 1.1 (0.3 - 4.1)
Diabetes mellitus, no 88 2.5 106 2.7 1.1 (0.8 - 1.5)
ICPC U98: Abnormal urine test 132 3.6 400 10.0 2.8 (2.3 - 3.4)*
18-45 years old 32 1.6 146 6.7 4.2 (2.8 - 6.3)*
46-65 years old 53 4.7 142 11.6 2.5 (1.8 - 3.5)*
> 65 years old 47 8.4 112 18.7 2.2 (1.6 - 3.2)*
Hypertension, yes 38 13.2 31 11.9 0.9 (0.5 - 1.5)
Hypertension, no 94 2.8 369 9.9 3.6 (2.8 - 4.5)*
Diabetes mellitus, yes 26 22.3 27 25.3 1.1 (0.6 - 2.0)
Diabetes mellitus, no 106 3.0 373 9.6 3.2 (2.6 - 4.0)*
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was modified by both the presence of the risk factors
hypertension and diabetes mellitus. For this diagnosis
the highest OR was found in patients without both con-
ditions (OR = 4.2).
In a previous study, the effects on participants of the
albuminuria self-test program were evaluated using a
questionnaire eight weeks after the start of the self-test
program [4,6]. There were positive results (high aware-
ness and newly detected diseases), but also some nega-
tive side-effects, such as false positive test results and a
low number of persons who visited their GP after a
positive test result [4]. With the results of that study it
was not possible to determine the consequences of the
self-test program for the GP. Therefore, in the present
study data from electronic medical records of GPs were
used to investigate the influence of the nationwide self-
test program in a large group of patients representative
for the Dutch population. In addition to this previous
study also the indirect influences of the program on the
number of newly detected kidney diseases could be
measured over the whole year after the self-test
program.
Previous studies have shown positive effects of mass
media campaigns on the effectiveness of screening.
Awareness of a mass media campaign is not only asso-
ciated with higher awareness of symptoms of a disease,
but also increases the screening rate [10-12]. Two stu-
dies reported that the response on cervical cancer
screening increased by 18-27% during a mass media
campaign [10,11]. This is in line with the results found
in this study. Despite the positive effects of mass media
campaigns on screening, there are only short-term
effects [10,11]. Mass media campaigns should be com-
bined with other approaches to achieve long-term
effects [10,12].
In this study we estimated the impact of a nationwide
self-test program on the number of newly diagnosed
patients with kidney diseases in general practice.
Although we used data from a large representative net-
work of GPs, this study has also a few limitations. For
instance, we could not correct for all potential con-
founding factors in the statistical analyses. Socio-eco-
nomic status, ethnic background, blood glucose levels,
high-density lipoprotein (HDL) levels and cigarette
smoking are not recorded by GPs in a systematic way
and therefore could not be used in this study [13,14].
Table 2 Incidence rates of kidney diseases/urinary complaints in general practice before (period 1) and after (period
2) the albuminuria self-test program per 10,000 person years in the total population and in subgroups (Continued)
ICPC U99: Urinary disease 507 13.8 1031 25.8 1.9 (1.7 - 2.1)*
18-45 years old 51 2.6 120 5.5 2.1 (1.5 - 3.0)*
46-65 years old 118 10.4 247 20.2 1.9 (1.6 - 2.4)*
> 65 years old 338 61.1 664 112.5 1.8 (1.6 - 2.1)*
Hypertension, yes 193 67.7 293 114.4 1.7 (1.4 - 2.0)*
Hypertension, no 314 9.3 738 19.7 2.1 (1.9 - 2.4)*
Diabetes mellitus, yes 113 97.7 139 132.7 1.4 (1.1 - 1.8)*
Diabetes mellitus, no 394 11.1 892 22.9 2.1 (1.8 - 2.3)*
1The absolute number of cases divided by the ‘time at risk’ of all patients in specified period (per 10,000 person years)
2 The incidence rate ratio is the person-time incidence rate of period 2 divided by the person-time incidence rate of period 1
* P < 0.05
Table 3 Risk of being newly diagnosed with a kidney
disease in general practice after the albuminuria self-test





ICPC U07: Urine symptoms/complaint 1.1 (1.0 - 1.3) 0.05
U07 * Diabetes mellitus 0.31
U07 * Hypertension 0.62
ICPC U14: Kidney symptoms/
complaint
1.7 (1.4 - 2.0) < 0.001
U14 * Diabetes mellitus 0.17
U14 * Hypertension 0.17
ICPC U27: Fears of urinary disease 1.0 (0.9 - 1.2) 0.53
U27 * Diabetes mellitus 0.02
U27 * Hypertension 0.01
ICPC U29: Urinary symptoms/
complaint
1.2 (0.9 - 1.5) 0.28
U29 * Diabetes mellitus 0.99
U29 * Hypertension 0.69
ICPC U98: Abnormal urine test 3.0 (2.4 - 3.6) < 0.001
U98 * Diabetes mellitus < 0.001
U98 * Hypertension < 0.001
ICPC U99: Urinary disease 2.1 (1.9 - 2.3) < 0.001
U99 * Diabetes mellitus < 0.01
U99 * Hypertension 0.06
#adjusted for gender, age, hypertension and diabetes
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Furthermore, the influence of the self-test program on
the number of newly diagnosed kidney complaints and
disease could be underestimated because of the used
registration method of the participating GPs. It is likely
that a part of the less specific kidney complaints have
been coded with an ICPC code in ICPC chapter A ‘Gen-
eral and unspecified’. On the other hand, the attention
for early detection of kidney diseases has increased the
last several years, which could have partly explained the
increased incidence ratio’s. Finally, the increased inci-
dence rates in the year after the self-test program could
be caused by early diagnosis of asymptomatic patients
and/or patients that would never be diagnosed without
screening, because of death before symptom onset or a
low risk of progression to end stage renal disease. It is
unknown to what extent these factors have biased our
results.
We found that the risk of being newly diagnosed by
the GP with kidney diseases and/or urinary complaints
one year after a nationwide albuminuria self test pro-
gram was higher, especially for patients without risk fac-
tors for kidney diseases (diabetes mellitus and
hypertension). The latter could be a result of periodic
screening on kidney diseases of patients with diabetes
and hypertension by the GP. According to the guidelines
of the Dutch College of General Practitioners, patients
with hypertension and diabetes should be monitored
every year by the GP [15-17].
Conclusions
It can be concluded that a nationwide albuminuria self-
test program resulted in an increasing number of newly
diagnosed kidney complaints and diseases the year after
the program. The highest numbers were found in
patients without risk factors for kidney diseases.
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